Performance of TB biomarker for targeted preventative therapy

An RNA signature of tuberculosis, RISK11, was used to discriminate between individuals with prevalent tuberculosis or progression to incident tuberculosis and individuals who remained healthy, according to a study in The Lancet Infectious Diseases.

Read the full story at Infectious Disease Advisor.